University of Minnesota Hospital. Seven hundred and fiftyfive were autotransplants, 1119, allogeneic transplants from related and 367 allogeneic transplants from unrelated donors. 
Clinical features, diagnostic and treatment data for patients with mycobacterial infections
Patient characteristics
Age/Sex liver dysfunction. Antituberculous treatment was adminisresolution of fever in 8 days. She had multiple other infective problems during her subsequent course but there tered for a total of 18 months. Despite the development of acute GVHD requiring systemic corticosteroid treatment, was no recurrence of mycobacterial infection. there was no reactivation of the tuberculous infection.
A 13-year-old Caucasian girl with common variable Central venous catheter tunnel inflammation immune deficiency developed MAI infection of the left maxillary sinus 103 days prior to allogeneic sibling transplanThree patients presented with inflammation along the central venous catheter tunnel due to infections with atypical tation. Sensitivities of this isolate are not available. Treatment was begun with INH, rifampicin and ethambutol and conrapid growing mycobacteria, M. chelonae and M. fortuitum. These infections occurred 7-90 days following the transtinued through the transplant period with only a temporary interruption. MAI was cultured again from the maxillary plant. The catheter had been in place for 1-5 months before the diagnosis of mycobacterial infection. The clinical sinus 22 days post-transplant when the patient was febrile but did not have local symptoms. INH was continued despite in course of one of them is described here.
A 12-year-old Caucasian girl, recipient of matched sibvitro resistance and streptomycin and erythromycin were added based on sensitivity profile. Antituberculous treatment ling donor transplant for aplastic anemia, presented with multiple 5 mm nodules along the central venous catheter was continued for 18 months with resolution of the infection.
track 90 days following the transplant. The catheter had been placed 1 month prior to transplant. She had normal Presentation with focal signs blood counts and no signs of GVHD. Biopsy and culture of one of these nodules revealed M. fortuitum infection. A 45-year-old Caucasian male received an autologous BMT for acute myeloid leukemia (AML) in second complete
The catheter was removed and she was treated with minocycline and trimethoprim/sulfamethoxazole with rapid resremission. In the immediate post-transplant period he developed severe pain in the lower thoracic spine region olution of infection. Treatment was continued for 6 months. She made an uneventful recovery. accompanied by persistent fever. Blood cultures were sterile. A MRI scan on day 15 showed evidence of inflammation in
In 10 other BMT recipients, 11 isolates of mycobacterial species were obtained on culture of various pathological the T 9 -T 10 vertebral disc space. A CT guided needle aspiration biopsy on day 17 yielded non-diagnostic necrotic tissue. specimens (two each from blood cultures, broncho-alveolar lavage specimens, bone marrow biopsies and post-mortem A repeat MRI scan obtained on day 26 because of persistent fever and worsening back pain showed loss of the T 9 -T 10 cultures of lung and liver, and one each from esophageal biopsy, peritoneal fluid and urine). Four isolates were M. forvertebral disc space with destruction of the adjoining T 9 and T 10 vertebral bodies. An open biopsy performed on day 30 tuitum or M. chelonae, three MAI, one M. terrae, one M. gordonae and two not speciated (non-M. tuberculosis). These revealed multiple granulomata and grew M. fortuitum. The patient was treated with amikacin, and clarithromycin for 4 were considered to be clinically insignificant based on the very low colony number (often a single colony), negative weeks followed by clarithromycin and ciprofloxacin for 9 months. His fever resolved and back pain improved within a repeat cultures and no concurrent clinical evidence suggestive of infection. week of starting antituberculous treatment.
Overall, mycobacterial infections were diagnosed following transplantation in only nine patients. There were six Fever of undetermined origin adults and three children. Three of the nine patients were known to be positive for PPD skin test prior to transplant A 46-year-old Hispanic male had an uncomplicated autologous transplant course for non-Hodgkin's lymphoma and had suggesting prior infection with mycobacteria. However, since several of the PPD non-reactive patients in this group achieved complete hematologic recovery by day 24. Seventy days post-transplant he developed low-grade fevers, weight were anergic on skin testing it is not possible to determine if they had previous infection with mycobacteria. Moreloss and elevated transaminase and alkaline phosphatase levels. A PPD skin test was strongly positive (20 mm induration over, the data regarding the pre-transplant PPD reactivity is not available in most BMT patients. Thus, it is not possafter 48 h). Bone marrow biopsy showed multiple granulomata positive for acid-fast bacilli, and bone marrow cultures ible to interpret the predictive value of a positive PPD skin test in our patient population. grew M. avium-intracellulare. Treatment with INH, rifampicin and ethambutol was administered for 18 months with uneventful resolution of the infection.
A 34-year-old Caucasian female, recipient of an alloDiscussion geneic unrelated donor transplant for CML in second chronic phase developed high grade fever with chills and
The incidence of mycobacterial infections has been increasing in recent years in the United States, particularly in certain rigors 52 days after transplant. She had normal blood counts and no evidence of GVHD. Despite broad-spectrum urban regions, primarily due to the epidemic of HIV infection. 3 In spite of the profound immunodeficiency developing antibacterial therapy, her fever continued and her central venous catheter was removed on day 55. Two days later, in bone marrow transplant recipients we observed a remarkably low incidence (0.49%) of mycobacterial infections. Only blood cultures drawn at the onset of fever were reported positive for mycobacteria which were later identified as two cases of M. tuberculosis infection were encounteredone diagnosed before transplant and one diagnosed 70 days M. chelonae. Treatment with cefoxitin, trimethoprim/ sulfamethoxazole, clarithromycin and amikacin resulted in post-transplant, yielding a crude incidence of 0.1% over the 20 years for which the transplant data were available for can mask the febrile response and obscure the granulomatous reaction to infection. Moreover, mycobacterial infecreview. Because of the low event rate, this can only be contions present with varied and nonspecific manifestations sidered an approximate estimation of the true incidence of and the isolation of mycobacteria often requires prolonged tuberculosis in this population. However, although low, the and specific culture techniques. Therefore, their clinical incidence of 0.1% is about 10 times the annual incidence management demands a high index of suspicion in order (approximately 0.01%) of tuberculosis cases reported in the to specifically request appropriate diagnostic studies to general population in the US. 4 The prevalence of tuberculosis identify mycobacterial infections. Furthermore, BMT infection in the Caucasian population in the US in 1990 was patients often have co-existence of multiple infectious estimated at 0.04%. 3 pathogens and, therefore, the existence or significance of Reports of mycobacterial infections in recipients of mycobacterial infections can be masked. We suggest that renal transplantation suggest an increased incidence of although mycobacterial infections are uncommon in BMT mycobacterial infections, frequently in extra pulmonary patients they should be considered in apparently infected sites. 5 The incidence of mycobacterial infections in BMT recipients, particularly those at higher risk because patients with other solid organ transplants is not known of previous tuberculosis exposure, positive PPD skin test as most of the relevant literature is case reports. 6 In or ethnic background. The optimal prophylaxis for patients patients with acquired immune deficiency syndrome at higher risk of mycobacterial infection is uncertain. (AIDS) a high incidence of mycobacterial infections, Patients identified to be PPD positive during pre-transplant both M. tuberculosis and non-tuberculous mycobacteria, evaluation may benefit from INH therapy started before and frequently in extra-pulmonary sites, has been reported. 7, 8 continued during transplant period. However, INH may In contrast, in our marrow transplant population, despite potentiate transplant related liver toxicity and the efficacy their severe immune suppression, we observed a relaof this approach has not been tested in the BMT setting. tively low incidence of mycobacterial infections. This may be due, at least in part to the prolonged duration of immune suppression in AIDS patients and recipients of solid organ transplants compared to the usual BMT
